Part 1 INTELLIGENT MEDICINE: Gut Health Innovations: Insights from Martha Carlin
by Kevin Danielson September 16, 2025
Martha Carlin, CEO and founder of the Bio Collective, details the significant influence of the microbiome on overall health. Martha discusses her unconventional path from accounting to microbiome research, sparked by her husband’s Parkinson’s diagnosis. Together, they explore the complex connections between gut health and diseases like Parkinson’s, autism, and even Alzheimer’s. Martha sheds light on groundbreaking research funded by NIH grants, the potential of machine learning and AI in understanding microbiome patterns, and the future prospects of personalized probiotics. Practical advice on maintaining a healthy microbiome, the impact of diet and exercise, and the intriguing intersections between gut health, neurochemistry, and systemic diseases are highlighted. The discussion also covers challenges in integrating microbiome research into clinical practice and potential future therapies.
Gratitude isn’t just a feeling. It’s a signal. A practice. A form of internal nourishment. It reshapes how we show up—for ourselves, our relationships, and even our microbiome.
In this wide-ranging conversation, Dr. Brian Lenzkes welcomes microbiome researcher and entrepreneur Martha Carlin to explore how our inner ecosystem shapes metabolic, neurological, and emotional health.
Martha shares how she discovered the connection between gut bacteria and Parkinson’s symptoms, developed probiotics that significantly improved her husband’s condition, and is now working on therapies for Crohn’s disease and post-antibiotic gut restoration. She also reveals the hidden dangers of glyphosate, explains why the “magic bullet” approach fails for complex diseases, and discusses the future of microbiome medicine.
In this episode, we discuss the surprising link between gut health and Parkinson’s, how glyphosate impacts your body on a cellular level, the microbiome’s role in chronic disease, and so much more.